Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

シンボルマーク: 2196.HK

HKSE

13.28

HKD

今日の市場価格

15.5749
PER（株価収益率
7.2266
PEGレシオ
63.71B
MRK キャップ
0.04%
DIV利回り

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196-HK) 財務諸表

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.の財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
balance-sheet.row.cash-and-short-term-investments	15582.1	17169.8	14549.2	11931.9	9989.9	9162.6	7468.2	6044.5	4062.4	3729.5	3111.6	5197.4	3125.9	3562.3	1308.5	1005.7	1079.6	991.3	752.9	688.1	1242.6	629.4	373.1	343.4	170	329.8	25.3	6.6	7.2
balance-sheet.row.short-term-investments	1888.5	928.5	4241.1	1970.1	456.7	616.1	219.3	48.5	33.8	33.8	44.2	224.8	231.3	218.8	11.7	0.1	5.8	2.1	0	5.2	0.2	285.3	0.9	0	0	0	0	0	0
balance-sheet.row.net-receivables	9967.9	10797.8	9517.7	7256.7	5873.4	5255.7	4522.5	2976.9	2518.7	3318.7	2256.4	1906.4	1797.3	1426.6	925.2	940.2	732.1	811	673.6	618.3	536.6	406.4	545.2	37.5	58.4	31.4	9.1	5.1	26.3
balance-sheet.row.inventory	7537.8	6882.4	5472.3	5162.8	3940.5	3287.4	2750.5	1670.7	1648.8	1604.6	1614.3	1273.4	1123.9	934.4	598	530.5	494.8	607.6	532	472.8	305.1	355.3	120.5	82.8	85	52.3	49.6	18	12.5
balance-sheet.row.other-current-assets	704.8	429.1	885.4	733.4	599.5	296	315.3	72.1	95.5	11.2	4.2	4.3	1.9	14.3	475.2	-59.2	210.6	6.5	3.3	0.5	19	16.1	6	207.7	117	96.6	132.7	77	57.4
balance-sheet.row.total-current-assets	33792.6	35279.2	30424.6	25084.8	20403.4	18001.7	15056.5	10764.3	8325.4	8664	6986.5	8381.5	6049.1	5937.7	3306.9	2417.3	2517.1	2416.4	1961.9	1779.7	2103.4	1407.2	1044.9	671.4	430.5	510.1	216.7	106.7	103.4
balance-sheet.row.property-plant-equipment-net	22239.4	16028.1	13283.9	13002.7	11085.1	9123.1	8315.9	6304.7	5764.9	5681.4	4907.5	3479.7	2627.3	1695.7	1258.8	1145.3	1139.1	1274.4	1240.6	1054	777.2	570.5	349.4	260.6	175.5	74.4	41.6	4.4	3.3
balance-sheet.row.goodwill	10852	10337.1	9400	8677.2	9014	8853.9	8464.3	3473.1	3303.4	3255	2976	1661.8	1585.1	296.4	51.1	51.1	51.1	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	17378.1	15925.3	13433.2	11498.6	10966.2	9192.1	8274.5	3650.6	3245.8	2911.9	2639.4	1782.3	1705.1	533.9	209	200.1	208.4	210.3	197.5	179	114.6	97.9	39.3	48	20.7	0.9	0.5	0	0
balance-sheet.row.goodwill-and-intangible-assets	28230.1	26262.4	22833.1	20175.9	19980.2	18046	16738.8	7123.7	6549.2	6166.9	5615.5	3444	3290.2	830.3	260.1	251.2	259.6	210.3	197.5	179	114.6	97.9	39.3	48	20.7	0.9	0.5	0	0
balance-sheet.row.long-term-investments	23123.8	24620.5	19679	21801.2	22564	23443.5	20904.5	18801.5	17200.5	14371.1	11560.7	9822.5	10011.5	7960.7	6652.3	3683.8	3465.1	2704.8	0	2108.4	1187.1	741.6	760.6	570.3	219.3	46.1	1.7	0	0
balance-sheet.row.tax-assets	624.5	442.6	265.6	244.9	196.1	173.1	144.5	129.6	102.5	101.2	88.1	31.5	16.7	18.4	11.4	12.9	11.8	5.6	0	20.1	36.5	322.4	15.5	-555.5	-211.5	10.6	10.3	0	0
balance-sheet.row.other-non-current-assets	5459.3	4531.2	6807.4	3376.5	1890.9	1763.9	810.8	644	259.3	351.6	316.9	347.9	295.9	377.5	37.6	28.5	42.3	22.3	2268.7	29.4	0	0	-2.4	576.3	223.8	4.9	16.3	0.2	0
balance-sheet.row.total-non-current-assets	79677	71884.7	62869.2	58601.2	55716.3	52549.6	46914.5	33003.5	29876.3	26672.3	22488.6	17125.6	16241.7	10882.5	8220.2	5121.6	4917.9	4217.5	3706.8	3390.8	2115.5	1732.4	1162.4	899.7	427.8	137	70.4	4.6	3.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	113469.6	107163.9	93293.8	83686	76119.6	70551.4	61971	43767.8	38201.7	35336.3	29475.2	25507.1	22290.8	16820.1	11527.1	7538.9	7435	6633.9	5668.7	5170.5	4218.8	3139.6	2207.3	1571.1	858.2	647.1	287.1	111.3	106.7
balance-sheet.row.account-payables	6159.6	6284	5063.7	3289	2397.3	2333.3	1781.9	1149.4	1048.6	905	1136.4	903.7	939.9	827.3	491.3	398	357.8	530.9	560.3	484	339.3	326.3	89.5	70.5	63.6	36.9	50.8	10.8	5.7
balance-sheet.row.short-term-debt	19555.1	17402.9	14547.6	14911.8	8920.5	10536.8	10478.2	5650.4	7334.2	3950.7	1424.2	875.3	2187.1	1830.4	1583	502.5	1556.4	1465.2	786.3	682	466.3	772.3	627.5	129.7	39.6	0	22.5	29.5	21
balance-sheet.row.tax-payables	537	929.8	727.5	564.7	759.6	478.9	480.1	478.2	503.8	342.9	288.9	162	111.7	247.4	48.9	49.5	73.7	42.1	27.8	38	62.6	61.3	9.5	16.2	8	12.1	10.4	0	-0.1
balance-sheet.row.long-term-debt-total	15554.5	12844.9	9697.4	9103	12987.1	12670.1	9814.9	5571	3571.5	3856.7	4199.7	4280.2	3915.1	2758.3	1284.5	1180.5	746.8	545.1	981.2	752.8	1026.9	45.8	25.2	25.2	13.8	30.1	0.5	0.4	14.3
Deferred Revenue Non Current	639.4	632.4	512.8	482.2	417.3	363.5	397.1	346.7	169.3	139.6	404.5	627.6	374.2	57.8	64.9	65.2	70.1	-449	-877.5	5.1	5.9	-38.8	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	125.2	9611.2	1528.6	54.6	249	4574.3	604.6	944.9	352.8	1337.1	309.5	729.9	221.9	110.6	67.6	541.3	44.1	18.8	40.1	33.6	34.1	32	27	16.4	9.2	37.3	0.6	22.7	34.1
balance-sheet.row.total-non-current-liabilities	23095.8	19756.9	15608.3	12829.4	19481.7	19035.4	15629.1	8408.9	6592.9	6696	6532.6	6309.3	5928.3	3723.4	2076.8	1337.8	900.5	642.4	1087.7	762.7	1035.3	53.9	25.2	27.9	13.8	42.1	0.5	0.4	14.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2049.6	745	648.4	627.3	410.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	56853.3	53055	44918.2	37701.7	36915.4	36958.6	32229.6	18517.5	17532.1	16233.3	11810.7	10202.5	10920	7426.9	4575.1	3093	3118.6	2985.3	2793.7	2356.7	2201.9	1466.2	884.7	352.6	201.1	116.4	154.5	79.3	81.1
balance-sheet.row.preferred-stock	1300.1	1198.4	1265.8	933.6	468	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	2672.4	2672.2	2562.9	2562.9	2562.9	2563.1	2495.1	2414.5	2314.1	2311.6	2240.5	2240.5	1904.4	1904.4	1237.8	1237.8	1237.8	952.1	832	826.5	381.9	381.9	293.8	293.8	226.1	150.7	58.8	20	20
balance-sheet.row.retained-earnings	24542.5	23216.9	21039.6	17505	15125.7	12771.5	11111.6	8993.8	6937	5457	7112.7	5703	4483.5	3717.7	3258.2	1184.8	715.1	262.9	349.3	411.3	372.5	182.1	143.4	108.6	114.4	46.8	27.5	6.2	2.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	-1300.1	-1198.4	-1265.8	-933.6	-468	-4436.3	-4000.5	-3047.9	-2592.5	-2164.5	-1671.5	-1213.5	-1061.4	-871.5	-654.1	-544.9	-478	0	-9	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	18469.9	18693.4	15589.5	16927.7	14199.5	17079.5	15720.6	13829.8	11523	11070.7	7650.6	6828.8	4445.4	3672.4	2634.7	2131.2	2397.4	1875.2	1218.6	1066.4	945.8	845.5	826.8	743.2	264.1	321.7	14.4	5.7	2.7
balance-sheet.row.total-stockholders-equity	45684.8	44582.5	39191.9	36995.5	31888.1	27977.7	25326.9	22190.2	18181.6	16674.8	15332.2	13558.8	9771.9	8423	6476.5	4008.9	3872.3	3090.2	2390.9	2304.1	1700.2	1409.5	1264	1145.5	604.5	519.1	100.7	32	25.6
balance-sheet.row.total-liabilities-and-stockholders-equity	113469.6	107163.9	93293.8	83686	76119.6	70551.4	61971	43767.8	38201.7	35336.3	29475.2	25507.1	22290.8	16820.1	11527.1	7538.9	7435	6633.9	5668.7	5170.5	4218.8	3139.6	2207.3	1571.1	858.2	647.1	287.1	111.3	106.7
balance-sheet.row.minority-interest	10931.5	9526.5	9183.6	8988.7	7316.1	5615	4414.6	3060.1	2488.1	2428.2	2332.3	1745.9	1599	970.2	475.5	437.1	444.1	558.3	484.2	509.7	316.7	263.9	58.7	73	52.6	11.6	32	0	0
balance-sheet.row.total-equity	56616.3	54108.9	48375.6	45984.3	39204.2	33592.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	25012.3	25549.1	23920.1	23771.3	23020.6	24059.6	21123.8	18850	17234.2	14404.9	11604.9	10047.3	10242.8	8179.4	6664	3683.9	3471	2706.9	2227.2	2113.6	1187.3	1026.9	760.6	570.3	219.3	46.1	1.7	0	0
balance-sheet.row.total-debt	35109.6	30247.7	24245	24014.8	21907.6	23206.9	20293.1	11221.3	10905.7	7807.4	5623.9	5155.5	6102.1	4588.7	2867.5	1683	2303.2	2010.3	1767.5	1434.8	1493.2	818.1	652.6	154.9	39.6	30.1	22.5	29.5	35.4
balance-sheet.row.net-debt	21416	14006.4	13936.9	14053	12374.4	14660.4	13044.2	5225.3	6877.1	4111.7	2556.5	183	3207.6	1245.2	1570.8	677.3	1229.4	1021.1	1014.6	752	250.8	474	280.4	-188.5	-130.4	-299.7	-2.8	22.9	28.2

キャッシュフロー計算書

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	2895.1	3947.5	4987.4	3940	3743.5	3019.9	3585.3	3221.3	2870.7	2369.8	2399.9	1839.3	1384.8	1000.3	2564.3	760.9	690.2	292.8	237.9	282.1	298.2	161.7	141.1	135.8	94.4	64.9
cash-flows.row.depreciation-and-amortization	2965.2	2335.9	1834.4	1666.2	1472.1	1320.1	938.6	732.9	649.3	558.4	415.5	286.2	209.9	152.7	134.7	132.5	136.5	132.1	116.7	91.1	56.1	37.6	28.6	28.1	20.1	9.3
cash-flows.row.deferred-income-tax	-2723.5	0	-4038.6	-2605.1	-2733	-1876.1	-2322.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	35.9	54.5	64.3	55.2	109.1	72.3	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-1081.2	-1387.9	259.7	-1401.4	-494.6	-535.1	-212.7	-288.1	-101.8	-555.3	-44.5	-28.2	-88.6	11	599.1	13.6	-133.7	-5.4	-107	789.2	23.2	-35	-45.2	0.8	-78	-10.8
cash-flows.row.account-receivables	1605.1	-2076.6	-1795	-1559.9	-863.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-333.9	-1430.1	-464.7	-1253.4	-505.2	-564.7	-491.1	-65.4	-88.3	-105	-149.6	-155.1	-99.8	-66.2	-70.1	-27.6	109.6	-42.7	-67	-27	56	-11.2	-37.5	12.4	-14.4	-4.9
cash-flows.row.account-payables	-1605.1	2076.6	1795	1559.9	863.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-2352.4	42.2	724.5	-148	10.6	29.6	278.4	-222.7	-13.4	-450.3	105.1	126.9	11.2	77.2	669.2	41.2	-243.3	37.2	-40	816.2	-32.8	-23.8	-7.7	-11.6	-63.6	-5.9
cash-flows.row.other-non-cash-items	1322.7	-732.4	841.5	924.9	1125.3	949	580.8	-1556.1	-1797.2	-1172.7	-1759.4	-1431.8	-1189.5	-960.6	-3036.2	-673.9	-561.5	-234.6	-59.3	-957.3	-227.3	-61.8	-56.3	-26.3	1.7	3.2
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-5336.7	-5888.8	-4972.6	-4437.1	-3962.1	-3174.9	-2170.6	-1922	-1235.5	-1119.4	-1040.1	-1160.6	-796.8	-339.2	-348.1	-210.6	-209.7	-266.6	-222.6	-205	-264.1	-139.5	-141.5	-126.6	-78	-52.2
cash-flows.row.acquisitions-net	-923.7	-487.6	381.4	-140.3	-818.8	-622.6	-7822.6	-249.4	109.9	-1145.7	-2225.2	30.8	12.7	2.1	-2.6	22.8	9.3	18.2	279.9	11.6	25.5	4.9	10.8	17.6	1	0
cash-flows.row.purchases-of-investments	-943	-1501.3	-1424.6	-1070.1	-517.9	-2133.4	-2525.7	-1395.7	-2955.3	-1943.2	-364.1	-759.1	-1500.3	-1190.2	-770.2	-563.2	-543.7	-399.3	-349	-665.1	-134.9	-475.3	-317.8	-345.5	-253.5	-46
cash-flows.row.sales-maturities-of-investments	2809.3	4649.5	2168.3	2037.2	4916.2	1243.4	1550.6	1492.6	2127	1515.9	1540.7	1484.7	615.5	1348	755.5	822.8	632.3	329.6	76.6	45.4	535.7	254.8	243.5	30.2	43.4	0.4
cash-flows.row.other-investing-activites	574.8	-835.9	-9.5	-1095.8	210.6	-557.4	464.2	-372.6	83.9	214.2	285.2	-574.4	-97.6	-85	-32.5	-15.6	58	-17	-222.6	33.9	-0.2	204.6	-282	-19.3	48.2	-2
cash-flows.row.net-cash-used-for-investing-activites	-3819.3	-4064	-3857	-4706.2	-172	-5244.9	-10504.1	-2447.1	-1869.9	-2478.3	-1803.5	-978.6	-1766.5	-264.3	-397.8	56.1	-53.7	-335.1	-437.7	-779.2	162.1	-150.5	-487.1	-443.6	-238.9	-99.8
cash-flows.row.debt-repayment	-21146.2	-26280.1	-27391.9	-15707.8	-13942.1	-9995.1	-9085.3	-9956.1	-7239.7	-2559.5	-2417.6	-3795.9	-4042.2	-2081.7	-1071.9	-1410.2	-1753.9	-1221	-817.9	-727.4	-665.6	-1613.8	-716.1	-311.2	-62.8	-52.4
cash-flows.row.common-stock-issued	0	0	0	0	0	4851.4	3017.6	2728.5	116.1	1466.1	30.5	3151.1	0	637.8	18.9	16.1	17.2	0	0	9	951.5	8.4	6.7	437.6	0	372.4
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	14821.2	7694.5	8990.2	4017.4	2105.1	-17.8	0	3083.4	1703.6	1286	2100.3	0	0	873.7	-589.4	1691	1200.8	-48.5	0	-342.4
cash-flows.row.dividends-paid	-2455.2	-2374.4	-1914	-1834.6	-1864.4	-1775.5	-1433.5	-1193.5	-1109.3	-962.7	-804.5	-500.9	-437.3	-297.4	-268.6	-257.9	-237.6	-371.9	-200	-149.2	-94.9	-89.8	-78.2	-14.1	-13.4	-9.7
cash-flows.row.other-financing-activites	22265.1	33083	28474.6	19009.5	13870.5	10056.8	2588.7	2172.7	-206.6	-98.3	154.3	3231.9	5392.5	480.3	18.9	16.1	17.2	1963.6	1165.7	8.5	984.4	24.1	41	402.5	117.1	369.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-1336.2	4428.5	-831.3	1467.1	-1936	3137.5	9908.6	1446	550.7	1863.1	-932.1	2068.4	913	1822.5	401	-349.9	143.1	370.7	147.8	14.6	586.1	19.9	454.2	466.3	41	337.7
cash-flows.row.effect-of-forex-changes-on-cash	73.6	128.3	-134.7	-300.2	-5.1	-18	-172.5	80.5	36.6	8.9	-31.4	-12	-6	-3.8	-0.7	-4.6	-4.8	-1.2	-0.4	0	-0.1	0	0	0.1	0	0
cash-flows.row.net-change-in-cash	-1667.7	4710.3	-874.2	-959.5	1109.4	824.7	1812.3	1189.4	338.4	593.9	-1755.3	1743.4	-542.9	1757.7	264.3	-65.4	216.1	219.3	-102	-559.5	898.3	-28.2	35.3	161.2	-159.7	304.5
cash-flows.row.cash-at-end-of-period	9502.4	11170.1	6450.7	7324.9	8284.4	7175	6350.3	4538	3348.6	3010.2	2416.3	4171.6	2428.2	2971.1	1213.4	949.1	1014.4	800.2	580.9	682.9	1242.4	344.1	372.3	343.4	170	329.8
cash-flows.row.cash-at-beginning-of-period	11170.1	6459.7	7324.9	8284.4	7175	6350.3	4538	3348.6	3010.2	2416.3	4171.6	2428.2	2971.1	1213.4	949.1	1014.4	798.4	580.9	682.9	1242.4	344.1	372.3	337	182.2	329.8	25.3
cash-flows.row.operating-cash-flow	3414.2	4217.6	3948.7	2579.8	3222.4	2950.1	2580.2	2110	1621	1200.2	1011.6	665.5	316.6	203.4	261.9	233	131.5	184.9	188.3	205.1	150.1	102.5	68.2	138.4	38.2	66.6
cash-flows.row.capital-expenditure	-5336.7	-5888.8	-4972.6	-4437.1	-3962.1	-3174.9	-2170.6	-1922	-1235.5	-1119.4	-1040.1	-1160.6	-796.8	-339.2	-348.1	-210.6	-209.7	-266.6	-222.6	-205	-264.1	-139.5	-141.5	-126.6	-78	-52.2
cash-flows.row.free-cash-flow	-1922.5	-1671.3	-1023.8	-1857.3	-739.6	-224.8	409.6	188.1	385.5	80.8	-28.4	-495.1	-480.2	-135.8	-86.2	22.4	-78.2	-81.7	-34.3	0.1	-113.9	-37	-73.4	11.8	-39.8	14.3

損益計算書の行

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. の売上は前期比 NaN% の変化。2196.HK の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996
income-statement-row.row.total-revenue	41399.5	43951.5	39005.1	30307	28585.2	24918.3	18533.6	14628.8	12608.6	12025.5	9996.4	7340.8	6485.5	4555.4	3872.3	3773.2	3693.3	3102	2988.5	2425.4	2154.6	1031.7	727.8	579.5	442.5	340.4	190.3	92.7	64.7
income-statement-row.row.cost-of-revenue	21595.3	23169.7	20228.3	13431.2	11543.4	10365.3	7609	6718.4	6308	6718.6	5543.4	4126.8	3991.1	2984.6	2610.7	2711.9	2693.8	2282.2	2076	1651.9	1564	668.1	448.9	307.6	248.4	209.3	116.5	65.3	50.1
income-statement-row.row.gross-profit	19804.2	20781.9	18776.8	16875.8	17041.7	14553	10924.6	7910.5	6300.6	5307	4453	3214	2494.4	1570.9	1261.6	1061.4	999.5	819.8	912.5	773.6	590.5	363.6	279	271.9	194	131.1	73.9	27.3	14.5
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-17.9	2683.7	2276.4	1841.5	1666	44.1	-13.2	181.9	78.3	324.6	97.9	89.9	158.8	62.1	56	30.9	21.9	60.5	96.5	52.8	42.7	18.1	12.3	18.9	10.9	8	10	-0.3	0.5
income-statement-row.row.operating-expenses	18240.9	17145	16055.8	14045.6	14425.7	12185.7	8621	6168.5	4827.1	4114.5	3339.1	2620.4	2149	1394.5	1098.2	939.7	834.5	794.6	829.5	658.2	549.4	304.1	206.9	172.3	102.3	62.6	31.6	14.3	4.9
income-statement-row.row.cost-and-expenses	39836.2	40314.7	36284.1	27476.8	25969.1	22551	16230	12886.8	11135.2	10833.1	8882.5	6747.2	6140.2	4379.1	3708.8	3651.6	3528.3	3076.7	2905.5	2310.1	2113.4	972.2	655.7	480	350.7	271.9	148.1	79.6	55
income-statement-row.row.interest-income	363.6	282.6	233.7	199.6	186.6	145.7	79.2	80.9	56.2	69.8	63.8	29.7	51.6	19.6	14.5	17.9	12.5	13.8	17.5	13.7	8.7	2.9	13.7	8.1	0	0	0	0	0
income-statement-row.row.interest-expense	1324.8	963.8	822.5	881	1074.7	929.7	577.5	488.2	470	415	350.5	370.6	314	162.4	132.4	149.6	130.6	83.3	72	37	45.9	36.2	23.7	9.8	-6.1	-3.3	3.1	3	1.5
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-42.9	-3722.2	-259.9	-43.3	-1887.5	1212.3	1758.1	1829.5	1898.4	1525.6	1792.3	1529.5	1381.3	1025.6	3101.2	714	591.4	249.1	124.7	159.4	282.5	104.1	76.8	42.6	12.8	5.2	-3.1	-3.1	-1.4
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-17.9	2683.7	2276.4	1841.5	1666	44.1	-13.2	181.9	78.3	324.6	97.9	89.9	158.8	62.1	56	30.9	21.9	60.5	96.5	52.8	42.7	18.1	12.3	18.9	10.9	8	10	-0.3	0.5
income-statement-row.row.total-operating-expenses	-42.9	-3722.2	-259.9	-43.3	-1887.5	1212.3	1758.1	1829.5	1898.4	1525.6	1792.3	1529.5	1381.3	1025.6	3101.2	714	591.4	249.1	124.7	159.4	282.5	104.1	76.8	42.6	12.8	5.2	-3.1	-3.1	-1.4
income-statement-row.row.interest-expense	1324.8	963.8	822.5	881	1074.7	929.7	577.5	488.2	470	415	350.5	370.6	314	162.4	132.4	149.6	130.6	83.3	72	37	45.9	36.2	23.7	9.8	-6.1	-3.3	3.1	3	1.5
income-statement-row.row.depreciation-and-amortization	2965.2	2335.9	2986.4	2171.8	1472.1	1320.1	938.6	732.9	649.3	558.4	415.5	286.2	209.9	152.7	134.7	132.5	136.5	132.1	116.7	91.1	56.1	37.6	28.6	28.1	20.1	9.3	-7	3.3	1
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	3307.5	8296.6	6313.7	4721.1	6413.2	3535.5	4074.9	3399.4	3297.2	2394.3	2818.8	2036	1580.5	1140.5	3212	807.6	736.7	347.1	234.5	298.2	329.4	168.5	144.1	141.9	106.3	77.3	49.3	9.8	8.7
income-statement-row.row.income-before-tax	3264.6	4574.4	6053.8	4677.8	4525.8	3579.6	4061.7	3571.5	3371.8	2718.1	2906.3	2123	1726.7	1202	3264.7	835.7	756.4	341	269.3	312.9	347.8	175.1	152.7	151.4	110.9	79.5	49.3	9.7	8.7
income-statement-row.row.income-tax-expense	369.5	626.9	1066.4	737.9	782.2	559.7	476.5	350.2	501.2	348.2	506.3	283.8	341.8	201.6	700.4	74.7	66.2	48.2	31.4	30.8	49.6	13.6	11.6	15.7	16.5	12.9	9.1	3.4	2.7
income-statement-row.row.net-income	2386.3	3730.8	4728.7	3662.8	3321.6	2707.9	3124.5	2805.8	2460.1	2112.9	2027.1	1563.9	1165.6	863.7	2498.2	690.9	625.8	259.2	159	215.3	263.6	147.2	135.5	128.5	92.2	63.7	36	6.4	6